Clustered genomic variants specific to patients who develop immune-related colitis after ipilimumab for prediction of toxicity.
Ahmad A. Tarhini
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
William A LaFramboise
No relevant relationships to disclose
Patricia Petrosko
No relevant relationships to disclose
Christopher G Deamont
No relevant relationships to disclose
John M. Kirkwood
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb